Wiliance Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 28-05-2024
- Paid Up Capital ₹ 0.50 M
as on 28-05-2024
- Company Age 11 Year, 18 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.09 M
as on 28-05-2024
- Revenue -3.25%
(FY 2020)
- Profit -42.87%
(FY 2020)
- Ebitda -21.68%
(FY 2020)
- Net Worth 13.03%
(FY 2020)
- Total Assets -8.67%
(FY 2020)
About Wiliance Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.09 M.
Archana Mishra, Brijendra Nigam, and Subhash Gautam serve as directors at the Company.
- CIN/LLPIN
U24232MP2013PTC031964
- Company No.
031964
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Dec 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Bhopal, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Wiliance Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Archana Mishra  | Director | 05-Sep-2019 | Current |
| Brijendra Nigam | Director | 31-Mar-2016 | Current |
| Subhash Gautam | Director | 17-Dec-2013 | Current |
Financial Performance of Wiliance Pharmaceuticals.
Wiliance Pharmaceuticals Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 3.25% decrease. The company also saw a substantial fall in profitability, with a 42.87% decrease in profit. The company's net worth Soared by an impressive increase of 13.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wiliance Pharmaceuticals?
In 2020, Wiliance Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Jan 2019 | ₹1.09 M | Open |
How Many Employees Work at Wiliance Pharmaceuticals?
Unlock and access historical data on people associated with Wiliance Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wiliance Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wiliance Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
